The Asco Post featured ITM investigator Mark Ratain, MD, who weighed in on the benefits of seamless trials for testing new drugs. Seamless trials – as opposed to trials split into distinct phases of testing – pose the opportunity for more efficient and effective studies.
“A lot of impetus for this meeting is to say how we can get rid of waste.”
-Mark Ratain, MD, Leon O. Jacobson Professor of Medicine, Director of the Center for Personalized Therapeutics, and Associate Director for Clinical Sciences at the Comprehensive Cancer Center
Source: The Asco Post